0001209191-13-053774.txt : 20131122
0001209191-13-053774.hdr.sgml : 20131122
20131122161943
ACCESSION NUMBER: 0001209191-13-053774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131120
FILED AS OF DATE: 20131122
DATE AS OF CHANGE: 20131122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDASSETS INC
CENTRAL INDEX KEY: 0001254419
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 510391128
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NORTH POINT CENTER EAST
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30022
BUSINESS PHONE: 6783232500
MAIL ADDRESS:
STREET 1: 100 NORTH POINT CENTER EAST
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rutherford John C
CENTRAL INDEX KEY: 0001311158
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33881
FILM NUMBER: 131238452
MAIL ADDRESS:
STREET 1: C/O INTERLINE BRANDS, INC.
STREET 2: 801 W. BAY STREET
CITY: JACKSONVILLE
STATE: FL
ZIP: 32004-1605
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-11-20
0
0001254419
MEDASSETS INC
MDAS
0001311158
Rutherford John C
100 NORTH POINT CENTER EAST
SUITE 200
ALPHARETTA
GA
30022
1
0
0
0
Common Stock
2013-11-20
4
S
0
2540
20.60
D
40292
D
Common Stock
2013-11-21
4
S
0
9460
20.70
D
30832
D
Restricted Stock
5944
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $20.62, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $20.78, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
/s/ Christopher K. Logsdon, Attorney-In-Fact
2013-11-22